Home RxNorm 2700724 HERCESSI 150 MG Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2700724
RxNorm name HERCESSI 150 MG Injection
Display name HERCESSI 150 MG Injection
Full name HERCESSI 150 MG Injection
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:38:51 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761346 Hercessi trastuzumab-strf 351(k) Biosimilar Rx 2026-08-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 285d2142-5bfa-401c-9246-7de21c4451af HERCESSI 150 MG Injection [PSN] · trastuzumab-strf 150 MG Injection [Hercessi] [SBD] · Hercessi 150 MG Injection [SY] 3 4 These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab). 20250321